Patents by Inventor Randal Byrn

Randal Byrn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110229874
    Abstract: The present invention provides compositions comprising cells that can effectively produce HCV after HCV infection, compositions for culturing the cells, methods for making the composition and methods for infecting the cells in the composition with HCV. The present invention also provides methods for assaying HCV production and methods for evaluating compounds that affect the production of HCV.
    Type: Application
    Filed: January 25, 2011
    Publication date: September 22, 2011
    Applicant: VERTEX PHARMACEUTICALS INCORPORATED
    Inventors: Ann Kwong, Randal Byrn, Lola M. Reid
  • Patent number: 7879606
    Abstract: The present invention provides compositions comprising cells that can effectively produce HCV after HCV infection, compositions for culturing the cells, methods for making the composition and methods for infecting the cells in the composition with HCV. The present invention also provides methods for assaying HCV production and methods for evaluating compounds that affect the production of HCV.
    Type: Grant
    Filed: March 27, 2002
    Date of Patent: February 1, 2011
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Ann Kwong, Randal Byrn, Lola M Reid
  • Publication number: 20050287514
    Abstract: The present invention provides compositions comprising cells that can effectively produce HCV after HCV infection, compositions for culturing the cells, methods for making the composition and methods for infecting the cells in the composition with HCV. The present invention also provides methods for assaying HCV production and methods for evaluating compounds that affect the production of HCV.
    Type: Application
    Filed: December 1, 2004
    Publication date: December 29, 2005
    Applicant: Vertex Pharmaceuticals Incorporated
    Inventor: Randal Byrn
  • Publication number: 20020142449
    Abstract: The present invention provides compositions comprising cells that can effectively produce HCV after HCV infection, compositions for culturing the cells, methods for making the composition and methods for infecting the cells in the composition with HCV. The present invention also provides methods for assaying HCV production and methods for evaluating compounds that affect the production of HCV.
    Type: Application
    Filed: March 27, 2002
    Publication date: October 3, 2002
    Inventors: Ann Kwong, Randal Byrn, Lola M. Reid